Fujitsu

Fujitsu is a global information and communication technology (ICT) giant that has become a critical infrastructure and technology partner for the pharmaceutical and healthcare industries. Through its 'Fujitsu Uvance' strategic framework, specifically the 'Healthy Living' vertical, the company provides advanced digital solutions including AI-driven drug discovery platforms, quantum-inspired computing for molecular simulation, and cloud-based healthcare data ecosystems. Rather than developing its own proprietary drug pipeline, Fujitsu focuses on accelerating the R&D and clinical trial processes for pharmaceutical companies. Its key offerings include the 'Digital Annealer' for rapid lead identification and 'Fujitsu Kozuchi,' an AI platform that utilizes generative AI and specialized Large Language Models (LLMs) to automate clinical trial documentation and optimize patient-to-trial matching. The company is currently a leader in addressing 'drug loss' in Japan by digitalizing the clinical trial ecosystem through strategic partnerships with healthcare providers and global clinical research organizations.